Nevertheless, several dirty drugs that aim for multiple targets at once are clinically effective in the treatment of complex diseases [240, 241], which might also underscore the therapeutic potential of the AP-2β for complex MNDs like obesity and neuroblastoma. This evidence concerns the gene TFAP2B and obesity disorder.